The official podcast of The Antibody Society.
We bring you conversations with scientists and innovators working in antibody research. Each episode explores the discoveries, collaborations, and breakthroughs in antibody engineering and therapeutic development. Hosted by Jonathan Davis of Creative Antibodies, with new episodes every month.
Antibodies! Ep. 3: Live from Antibody Engineering & Therapeutics, San Diego, USA
Recorded live at Antibody Engineering & Therapeutics in San Diego, Episode 3 of Antibodies! brings together leading voices from across the antibody discovery and development community for a series of conversations on some of the field’s most important challenges and opportunities.
Hosted by Jonathan Davis, PhD, Founder of Curated Antibodies, this special conference edition features discussions on target discovery, tumor specificity, bispecific and trispecific antibodies, intracellular targets, antibody developability, Fc effector functions, nanobody discovery, and the growing role of artificial intelligence in antibody research.
Featured guests include:
Kat Harris, PhD (Rondo Therapeutics; President, The Antibody Society)
Bryan Glaser, PhD (Invenra)
Bassil Dahiyat, PhD (Xencor)
Jay (Johnson & Johnson)
Shashi Jagtiani (SeromYx Systems)
Brandon DeKosky, PhD (MIT & Ragon Institute)
Chris St. George (Nanobody Discovery)
From emerging antibody formats and next-generation targeting strategies to AI-enabled discovery and developability assessment, this episode offers a snapshot of the ideas shaping the future of antibody therapeutics.
22 Jan 2026
Antibodies! Ep. 2: Fc Engineering & Bispecifics with John Desjarlais
Antibodies! Ep. 2: Fc Engineering & Bispecifics with John Desjarlais
We’re excited to share Episode 2 of the Antibodies! podcast, recorded live at the Antibody Engineering & Therapeutics conference in San Diego.
Host Dr. Jonathan Davis PhD (Founder, Creative Antibodies) sits down with John Desjarlais PhD, Chief Scientific Officer at Xencor, to discuss learnings from two decades of antibody engineering: Fc platforms, T-cell engagers in solid tumors, and bispecifics in autoimmune disease.
In this conversation, they discuss:
- How a classical trombonist ended up engineering some of the most widely used Fc platforms in antibody therapeutics
- The KLH study that proved obexelimab could shut down B cells. Data so meaningful, John still keeps the plot on his office wall
- Why target selectivity matters more than immune environment for T-cell engagers in solid tumors
- The autoimmune gold rush: using T-cell engaging bispecifics to reset the immune system, inspired by Georg Schett’s CAR-T breakthrough
- Trispecifics, AND-gate targeting, and where bispecifics can go beyond oncology
Be sure to listen all the way to the end for a surprise treat - an improvised harmonica blues duet between Jonathan and John!
If you missed our previous episodes, you can find them here: https://tabs-antibodiespodcast.podbean.com/
19 Jan 2026
Antibodies! Ep. 1: The Antibody Frontier with Dr. Janine Schuurman
The Antibody Society is proud to launch “Antibodies!”, our official podcast series exploring the science, stories, and people in antibody discovery, engineering, and therapeutic innovation.
For our debut episode, host Dr. Jonathan Davis (Founder, Creative Antibodies) sits down with Dr. Janine Schuurman (Board member and current President of The Antibody Society & Founder, Lust for Life Science B.V., formerly SVP Antibody Research & Technology of Genmab).
In this conversation, they reflect on their professional journeys and discuss:
- The mission of The Antibody Society.
- The power of community and collaboration.
- How unexpected results can lead to meaningful discoveries.
- The joy and importance of creativity, curiosity, and experimentation.
- How camaraderie sustains the antibody scientific community.
We sincerely hope you will enjoy this episode and stay with us for more conversations to come!
If you missed our previous episodes, you can find them here: https://tabs-antibodiespodcast.podbean.com/
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
5.0 / 5
4 ratings
Contact Antibodies!
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Antibodies!?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine